AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 12 filers reported holding AKARI THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $510 | -6.1% | 3,000 | 0.0% | 0.00% | – |
| Q1 2023 | $543 | -61.4% | 3,000 | 0.0% | 0.00% | – |
| Q4 2022 | $1,407 | -29.6% | 3,000 | 0.0% | 0.00% | – |
| Q3 2022 | $2,000 | -33.3% | 3,000 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 3,000 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -20.0% | 3,000 | 0.0% | 0.00% | – |
| Q3 2021 | $5,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q2 2021 | $5,000 | -37.5% | 3,000 | 0.0% | 0.00% | – |
| Q1 2021 | $8,000 | +33.3% | 3,000 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | +20.0% | 3,000 | 0.0% | 0.00% | – |
| Q3 2020 | $5,000 | -28.6% | 3,000 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +40.0% | 3,000 | -7.6% | 0.00% | – |
| Q1 2020 | $5,000 | 0.0% | 3,246 | +8.2% | 0.00% | – |
| Q4 2019 | $5,000 | 0.0% | 3,000 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | -77.3% | 3,000 | +99.5% | 0.00% | – |
| Q4 2015 | $22,000 | – | 1,504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omnia Family Wealth, LLC | 467,085 | $761,000 | 0.52% |
| Hikari Power Ltd | 89,815 | $146,000 | 0.02% |
| NEA Management Company, LLC | 452,167 | $737,000 | 0.01% |
| Truvestments Capital LLC | 1,621 | $3,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 30,264 | $49,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 15,276 | $25,000 | 0.00% |
| MORGAN STANLEY | 5,539 | $9,000 | 0.00% |
| Renaissance Technologies | 65,350 | $107,000 | 0.00% |
| Citadel Advisors | 37,770 | $62,000 | 0.00% |
| HighTower Advisors, LLC | 20,000 | $33,000 | 0.00% |